Dr. Nina D’Abreo, is an Attending Physician in the Department of Oncology and Hematology at the Perlmutter Cancer Center at NYU Winthrop-University Hospital and Medical Director of NYU-Winthrop’s Breast Health Program. She serves on the Breast Cancer Medical Advisory Committee at NYU-Winthrop, which is dedicated to improving all aspects of breast health. She is responsible for developing the Breast Clinical Trials Program at Winthrop and serves as the local Principal Investigator of several cooperative group-sponsored breast cancer clinical trials designed for breast cancer prevention, early stage and metastatic breast cancer. Dr. D’Abreo is Clinical Assistant Professor of Medicine at NYU Langone School of Medicine. She is focused on the personalized treatment of breast cancer, and has a particular interest in breast cancer survivorship. She has widely spoken and published on the subject of breast cancer.

The Brightening Outlook for Patients with HER2+ Breast Cancer

By Nina D’Abreo, MD ON August 15, 2022

Not all breast cancers are created equal. Historically those patients with hormone-driven breast cancer had better outcomes compared to those with HER2+ breast cancer. Human epidermal growth factor receptor 2 (HER2)/Neu is a kinase protein involved in normal cell growth. Sometimes there are errors in the genes that control the HER2 protein. This causes us to [...]

How Do Breast Cancer Vaccines & Immunotherapy Treatments Work?

By Nina D’Abreo, MD ON September 18, 2018

At our hospital, we get a lot of questions about immunotherapy treatments for breast cancer. Immunotherapy is one of latest, most promising lines of research in breast cancer, part of a growing breed of biologic therapies. Immunotherapy is often mentioned in the same context as the coveted “breast cancer vaccine.” Although immunotherapy and cancer vaccines are still in the research phase, many believe immunotherapy alone, or [...]

Tamoxifen, Raloxifene & Aromatase Inhibitors: How Breast Cancer Prevention Drugs Work

By Nina D’Abreo, MD ON January 29, 2018

If you or a loved one has increased risk factors for breast cancer, developing a risk reduction plan is an important conversation to have with your doctor. At our hospital, we always recommend tackling obesity and alcohol usage first, but for those at high risk, chemoprevention can be a small piece of the risk reduction [...]